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The objective of this study was to determine the risk factors
of postoperative acute renal failure (ARF) in orthotopic liver
transplantation (OLT). We reviewed 184 consecutive OLT.
Postoperative ARF was defined as a persistent rise of 50%
increase or more of the S-creatinine (S-Cr). The patients were
classified as early postoperative ARF (E-ARF) (first week) and
late postoperative ARF (L-ARF) (second to fourth week).
Preoperative variables were age, sex, comorbidity, indication
for OLT, Child–Pugh stage, united network for organ sharing
status, analysis of the blood and urine, and donor’s data.
Intraoperative variables were systolic arterial pressure, mean
arterial pressure, pulmonary capillary wedge pressure,
cardiac index, and systemic vascular resistance index.
Surgical technique, number of blood products transfused,
need for adrenergic agonist drugs, and intraoperative
complications were also important. Postoperative variables
were duration of stay in the intensive care unit, time on
mechanic ventilation, liver graft dysfunction, need for
adrenergic agonist drugs, units of blood products infused,
episodes of acute rejection, re-operations, and bacterial
infections. Firstly we carried out a univariate statistical
analysis, and secondly a logistic regression analysis. The risk
factors for E-ARF were: pretransplant ARF (odds ratio
(OR)¼ 10.2, P¼ 0.025), S-albumin (OR¼ 0.3, P¼ 0.001),
duration of treatment with dopamine (OR¼ 1.6, P¼ 0.001),
and grade II–IV dysfunction of the liver graft (OR¼ 5.6,
P¼ 0.002). The risk factors for L-ARF were: re-operation
(OR¼ 3.1, P¼ 0.013) and bacterial infection (OR¼ 2.9,
P¼ 0.017). The development of E-ARF is influenced by
preoperative factors such as ARF and hypoalbuminemia, as
well as postoperative factors such as liver dysfunction and
prolonged treatment with dopamine. The predicting factors
of L-ARF differ from E-ARF and correspond to postoperative
causes such as bacterial infection and surgical re-operation.
Kidney International (2006) 69, 1073–1080. doi:10.1038/sj.ki.5000216;
published online 1 February 2006
KEYWORDS: liver transplantation; acute renal failure; risk factors; multivariate
analysis
Postoperative acute renal failure (ARF) is a serious clinical
problem in orthotopic liver transplantation (OLT). The true
incidence is not known due to the differences in the selection
of patients and in the criteria and methods used to evaluate
renal function. The rate of ARF after OLT varies between 51
and 94%,1–3 and between 8 and 17% need renal replacement
therapy (RRT).3,4 Moreover, postoperative ARF results in a
high mortality, which has been linked to the serum creatinine
(S-Cr) peak,2 the need for postoperative dialysis,4 the
duration of RRT,5 and the presence of other co-morbidities
such as sepsis, encephalopathy, and coagulopathy.6
Various factors may influence, to a different extent, the
origin of ARF after OLT. Some depend on the clinical state
of the recipient before transplant and others stem from
intraoperative hemodynamic changes and postoperative com-
plications.3,7,8 Postoperative ARF has been divided, arbitrarily,
into early postoperative ARF (E-ARF) and late postoperative
ARF (L-ARF) depending on how long after the operation it
occurs, and etiopathogenic differences have been suggested,
although these have not been reliably confirmed. To date there
is no specific treatment available for ARF. Preventive measures
such as careful adjustment of drug doses and of the
hydroelectrolytic balance, together with dialysis in the serious
cases, are the most effective therapeutic measures. Conse-
quently, there is a growing interest in identifying the risk factors
for ARF after OLT, which would allow a better understanding
of the illness and enable preventive measures to be adopted.
The objective of this study was to identify the independent
risk factors of both E-ARF and L-ARF in patients who had
undergone OLT in our hospital.
RESULTS
Fifty-seven (30.9%) patients had E-ARF and 34 (19.1%)
L-ARF, with an overall incidence in the first month after
surgery of 48%. The most frequent etiologies of E-ARF were
ischemic acute tubular necrosis and pre-renal ARF, whereas
those of L-ARF were multifactorial ARF, followed by cyclo-
sporine nephrotoxicity and sepsis-associated ARF (Table 1).
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Patients with E-ARF and L-ARF showed similar clinical
manifestations with regard to the following variables:
oliguria, maximum S-Cr, the percentage of patients under-
going dialysis, and the duration of ARF. However, the
duration of RRT was significantly longer in patients with
E-ARF (Table 1). The mean S-Cr, on the 30th day post-OLT,
was 1.4 mg/dl in E-ARF group, 1.86 mg/dl in the L-ARF
group, and 1 mg/dl in patients without ARF. Two patients in
the L-ARF group received dialysis temporarily on the 30th
day post-OLT. In the first month post-transplant, 17 patients
died, six (10.5%) from the E-ARF group, seven (20.5%) from
the L-ARF group, and four from the group without any
postoperative ARF. The global postoperative mortality was
greater in patients with ARF than in those without ARF, 13
(16.7%) vs 4 (3.8%), respectively (Po0.01).
Univariate analysis for E-ARF
The E-ARF and non-E-ARF groups were homogeneous with
respect to age, sex, and medical background (abdominal
surgery, diabetes, arterial hypertension, and nephropathy).
Table 1 | Etiology and clinical data in liver transplantation






Prerenal azotemia 18 (32) 5 (13) o0.05
Ischemic ATN 24 (42) 1 (3) o0.001
Hepatorenal syndrome 0 1 (3) NS
Cyclosporine nephrotoxicity 0 8 (22) o0.001
Sepsis-associated ARF 1 (2) 7 (19) o0.01
Multifactorial ARF 14 (25) 15 (40) NS
Clinical of ARF
Oliguria 14 (25) 9 (24) NS
Peak S-Cr (mg/dl) 2.2 (1.5–5.9) 2 (1.4–5.6) NS
Duration of the ARF (days) 5 (1–21) 7 (2–20) NS
Patients in dialysis 15 (26) 7 (19) NS
Need of dialysis (days) 6 (1–14) 4 (2–6) o0.001
The values are the number and (%) of patients.
Results of quantitative data are expressed as median (and range).
ATN, acute tubular necrosis; ARF, acute renal failure; E-ARF, early acute renal failure;
L-ARF, late acute renal failure; NS, not significant; S-Cr, serum creatinine.
Table 2 | Comparison of preoperative, intraoperative, and postoperative variables in OLT patients who did or did not develop
E-ARF (univariate analysis)
Variable E-ARF (N=57) Non-E-ARF (N=127) P
Preoperative
Age (year) 48710 45714 NS
Sex (male/female) 49 (86)/8 (14) 93 (73)/34 (27) NS
UNOS status: class 1/2/3 10 (18)/15 (26)/32 (56) 1 (0.8)/17 (14)/107 (86) o0.01
Prothrombin time (seconds) 7.277.9 4.374.2 NS
Serum creatinine (mg/dl) 1.1670.64 0.8970.21 NS
Serum bilirubin (mg/dl) 6.777.6 577.5 o0.05
Serum albumin (g/dl) 3.2870.5 3.6970.7 o0.001
Urgent retransplant 8 (14) 0 (0) o0.01
Child–Pugh score: A/B/C 0 (0)/13 (37)/22 (63) 15 (17)/47 (52)/28 (31) o0.001
Urinary alterations (hematuria and/or proteinuria) 20 (35) 20 (16) o0.01
Preoperative ARF 12 (21) 3 (2) o0.001
Intraoperative non-hemodynamics
RBC transfusions (units) 26717 16712 NS
Fresh frozen plasma (units) 24712 16710 o0.001
Platelets (units) 12712 778 NS
Cryoprecipitate (units) 18712 11712 o0.001
Intraoperative complications 13 (23) 11 (9) o0.05
Noradrenaline 36 (63) 47 (37) o0.01
Dobutamine 19 (33) 23 (18) o0.05
Surgery: standard/VVB/PGB 33 (58)/10 (17)/14 (25) 51 (40)/10 (8)/66 (52) o0.001
Postoperative
ICU stay (days) 12.977.4 7.274.0 NS
Mechanical ventilation (days) 6.676.3 2.572.7 o0.01
RBC transfusions (units) 4.574.4 1.872.3 NS
Fresh frozen plasma (units) 10.176.9 6.674.7 NS
Platelets (units) 16.1715.1 9712.3 o0.001
Dobutamine (days) 2.772.7 0.771.5 NS
Dopamine (days) 5.471.9 3.272.2 o0.001
Cyclosporine level (ng/ml) 2727106 253794 NS
Graft dysfunction (II–III–IV) 24 (42) 20 (16) o0.001
Bacterial infection 23 (40) 28 (22) o0.05
Acute rejection 8 (14) 50 (39) o0.001
The values are number and (%) of patients.
The results of quantitative data are expressed as mean7s.d.
E-ARF, early acute renal failure; ICU, intensive care unit; OLT, orthotopic liver transplantation; NS, not significant; PGB, piggy back; RBC, red blood cells; UNOS, united network
for organ sharing; VVB, venovenous bypass.
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The univariate study of the main preoperative variables is
shown in Table 2. Patients with E-ARF more frequently
presented urgent retransplant indication (Po0.01), Child–Pugh
score C (Po0.001), united network for organ sharing status 1
and 2 (Po0.001), higher levels of S-bilirubin (Po0.05), lower
levels of S-albumin (Po0.001), a higher rate of urinary changes
(proteinuria and/or hematuria) (Po0.01), and a higher rate of
preoperative ARF (Po0.001) than patients without E-ARF.
The univariate analysis of non-hemodynamic intraopera-
tive variables showed that in patients with E-ARF the number
of units of all blood products infused was greater, but only
reached statistic significance in those of fresh frozen plasma
(Po0.001) and cryoprecipitate (Po0.001). We registered 27
intraoperative incidences in 24 patients: 11 fibrinolysis, seven
portal vein thrombosis, three air embolisms, three hepatic
artery thrombosis, one gastrointestinal hemorrhage, one
anaphylactic shock, and one ventricular fibrillation. Patients
with E-ARF had a higher rate of intraoperative complications
(Po0.05) and a greater need of support with dobutamine
(Po0.05) and noradrenaline (Po0.01). The standard
surgical technique were used more frequently than ‘Piggy-
back’ technique (PGB) in patients with E-ARF (Po0.001)
(Table 2).
Patients with E-ARF had lower systolic arterial pressure in
the anhepatic (Po0.01) and post-anhepatic phases (Po0.05),
lower mean arterial pressure (MAP) in the anhepatic and
post-anhepatic phases (Po0.05), higher pulmonary capillary
wedge pressure in the pre-anhepatic phase (Po0.05), and a
lower cardiac index in the post-anhepatic phase (Po0.01)
than patients without E-ARF (Table 3).
In the postoperative period, patients with E-ARF needed
artificial ventilation for a longer period (Po0.01), a higher
number of platelet units infused (Po0.001), dopamine
support for a greater number of days (Po0.001), and
presented liver graft dysfunction (Po0.001) and bacterial
infections (Po0.05) with greater frequency than patients
without E-ARF. The incidence of acute rejection was
significantly less in the E-ARF group (Table 2).
Risk factors for E-ARF
In the multivariate analysis, four independent risk factors for
E-ARF were found: preoperative ARF (odds ratio
(OR)¼ 10.2, P¼ 0.025), preoperative S-albumin (OR¼ 0.3,
P¼ 0.001), duration of treatment with dopamine (OR¼ 1.6,
P¼ 0.001), and grade II–IV dysfunction of the liver graft
(OR¼ 5.6, P¼ 0.002). The cut-off point used for the
quantitative variables was the value of the median in the
E-ARF group: 3.2 g/dl for the S-albumin and 6 days for the
dopamine treatment duration (Table 4).
All the patients with preoperative-ARF had an S-Cr level
of above 1.5 mg/dl. In Table 5, we show the characteristics of
Table 3 | Hemodynamic results in OLT with E-ARF and non-E-ARF
Variable Moment E-ARF Non E-ARF P
SAP (mmHg) A 116728 112719 NS
B 105721 116721 o0.01
C 122735 135730 o0.05
MAP (mmHg) A 79717 79713 NS
B 78716 84714 o0.05
C 84724 92721 o0.05
PCWP (mmHg) A 1374 1273 o0.05
B 1074 974 NS
C 1775 1775 NS
CI (l/min/m2) A 572 4.971.7 NS
B 4.271.9 4.772.2 NS
C 671.8 772.1 o0.01
SVRI (din seg/cm5/m2) A 1.2907690 1.2327451 NS
B 1.5787789 1.5117625 NS
C 8447390 8487339 NS
The results of quantitative data are expressed as mean7s.d.
CI, cardiac index; MAP, mean arterial pressure; NS, not significant; OLT, orthotopic liver transplantation; PCWP, pulmonary capillary wedge pressure; SAP, systolic arterial
pressure; SVRI, systemic vascular resistance index.
Moment A, after anesthesia induction; Moment B, 5 min at the start of anhepatic phase; Moment C 5 min at the start of post-anhepatic phase.
Table 4 | Results of risk factors of E-ARF and L-ARF in
multivariate analysis
Variable OR (95% CI) P
E-ARF
Serum albumin o3.2 g/dl 0.3 (0.2–0.4) =0.001
Preoperative ARF 10 (1.3–78) =0.025
Treatment with dopamine 46 days 1.6 (1.3–2.1) =0.001
Graft dysfunction II–IV vs I 5.6 (1.8–17) =0.002
L-ARF
Surgical re-operation 3.1 (1.2–7.8) =0.013
Bacterial infection 2.9 (1.2–7.0) =0.017
ARF, acute renal failure; CI, confidence interval; E-ARF, early acute renal failure;
L-ARF, late acute renal failure; OR, odds ratio; S-Cr, serum creatinine.
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these patients: 15 patients presented preoperative ARF, the
most frequent etiology being hepatorenal syndrome (n¼ 10);
urgent retransplant was the most frequent indication of OLT
(n¼ 8); nine patients were admitted to the intensive care unit
before OLT; 10 needed intraoperative RRT; 12 developed
E-ARF; 10 needed early-postoperative RRT; six developed
L-ARF; and finally, seven died in the first month post-OLT.
Univariate analysis for L-ARF
In all, 178 OLT were analyzed for the L-ARF statistical study.
The variables found to have statistical significance in the
univariate analysis are shown in Table 6. The postoperative
variables are significant. The patients in the L-ARF group
presented mechanical ventilation for a longer period of time
(Po0.05), more units of concentrate of platelets infused
(Po0.05), and a higher rate of surgical re-operations
(Po0.001) and of bacterial infections (Po0.001) than the
patients without L-ARF.
Risk factors for L-ARF
In the logistic regression analysis, two independent risk
factors for L-ARF were found: surgical re-operation
(OR¼ 3.1 and P¼ 0.013) and bacterial infection (OR¼ 2.9
and P¼ 0.017) (Table 4).
Of the 44 patients who required re-operation, 39% were
due to intra-abdominal bleeding, 25% due to biliary fistulas,
14% due to intra-abdominal abscesses, and 22% due to other
causes. The 45% of the re-operations were performed during
the first week and the 55% between the second and fourth
weeks after OLT.
There were 51 episodes of bacterial infection, distributed
between bacteremia (47%), intraabdominal infection (28%),
pulmonary infection (20%), and other causes (one cervical
abscess, one endocarditis, and one cellulitis) (5%). Bacterial
infection has been produced by microorganisms that are
typically nosocomial. Of these, 24% occurred during the first
week, and the 76% between the second and fourth weeks
after OLT.
DISCUSSION
The global rate of postoperative ARF in our series was
comparatively lower than in others who used the same
criteria for ARF.1,2 The lower doses of cyclosporine used, the
beginning of the cyclosporine treatment after surgery, the fact
that aminoglucoside antibiotics were avoided, and the fact
that in almost half of the patients the technique of PGB was
employed are factors which may have helped to reduce this
rate.9
In this study, we have tried to identify the etiology of ARF
by using clinical and hemodynamic data and normal
laboratory tests of the blood and urine. We think that the
etiological diagnosis of postoperative ARF in OLT is possible,
although the real cause may be difficult to establish due to the
large number of diverse factors. Our findings suggest that
there are differences in the etiology of E-ARF and L-ARF. In
the early postoperative period, prerenal and ischemic acute
tubular necrosis are the principal causes of ARF, which is in
agreement with previous publications by McCauley et al.2
and Ishitani et al.5 The zero incidence of cyclosporine
nephrotoxicity etiology in the E-ARF group can be accounted
for because the treatment with cyclosporine was started 12 h
after OLT and with smaller doses than in other series.1
However, the fact that cyclosporine played some etiological
role in the 14 episodes of multifactorial E-ARF cannot be
discounted. On the other hand, in the late postoperative
period multifactorial ARF is the most common etiology,
although cyclosporine nephrotoxicity and sepsis-associated
ARF are also meaningful.
Risk factors for E-ARF
In our series, we found that preoperative ARF is an
independent risk factor for E-ARF. In other studies, either



















1 HRS/AHF u-RT 1 Yes 3.3 Yes (8 d) — Dead
2 HRS/AHF u-RT 1 Yes 2.2 Yes (3 d) Non Alive
3 HRS/AHF u-RT 1 Non 2 Yes (3 d) Yes (4 d) Dead
4 HRS/AHF FH 1 Yes 4.1 Yes (10 d) Non Alive
5 HRS/AHF u-RT 1 Yes 1.5 Yes (6 d) Non Dead
6 HRS/AHF u-RT 1 Yes 2.5 Yes (7 d) — Dead
7 HRS/AHF u-RT 1 Yes 2.1 Yes (4 d) Non Alive
8 IS-N e-RT 3 Non 1.5 Non Non Alive
9 HRS/AHF u-RT 1 Yes 1.6 Yes (1 d) Non Alive
10 IS-N e-RT 2 Non 1.7 Yes (0) Yes (0) Alive
11 HRS class I LC 2 Yes 1.9 Yes (8 d) — Loss of the
graft
12 IS-N e-RT 2 Non 1.8 Non Yes (0) Dead
13 MF-ARF e-RT 2 Yes 1.7 Yes (0) Yes (0) Dead
14 HRS/AHF u-RT 1 Yes 2 Yes (6 d) Yes (2 d) Dead
15 PRE-ARF LC 3 Non 1.7 Non Yes (0) Alive
ARF, acute renal failure; e-RT, elective retransplant; FH, fulminant hepatitis; HRS/AHF, hepatorenal syndrome/acute hepatic failure; IS-N, immunosuppressant nephotoxicity;
LC, liver cirrhosis; MF-ARF, multifactorial acute renal failure; OLT, orthotopic liver transplantation; PRE-ARF, prerenal acute renal failure; RRT, renal replacement therapy; S-Cr,
serum creatinine; u-RT, urgent retransplant; UNOS, united network for organ sharing. UNOS status: 1, ICU; 2, hospital; 3, home.
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S-Cr 41 mg/dl8,10 or 41.5 mg/dl3 before OLT were factors
predicting postoperative RRT. Our patients with preoperative
ARF had a worse united network for organ sharing status, a
higher rate of re-transplants, a higher rate of severe ARF, and
a greater postoperative mortality. Lafayette et al.10 and Baliga
et al.11 report a worse united network for organ sharing
status, greater need for postoperative RRT, and lower survival
rate in patients with preoperative renal dysfunction. More-
over, the high mortality in this group of patients is in
agreement with the findings of previous studies.12,13 Patients
with hepatorenal syndrome have a lower post-transplant
survival rate,12 especially when it is associated with fulminant
liver failure.13 The important prognosis of the preoperative
renal function has been taken up by the model for end-stage
liver disease score to give priority in the waiting list for
OLT.14,15 At present, the mechanism by which preoperative
ARF worsens the prognosis of liver transplants is not known.
It has been suggested that renal insufficiency is an indicator
of the severity of the underlying disease,10 and that it is
associated with a higher rate of intraoperative haemor-
rhage,16 postoperative infection,10 and primary dysfunction
of the graft.17
A decrease in preoperative S-albumin is a prognostic
factor in patients with cirrhosis of the liver18 and in those
who undergo major surgical operations.19 In liver transplan-
tation, various studies show that preoperative hypoprotein-
emia3 and hypoalbuminemia20 are associated with a greater
incidence of postoperative ARF. Patients with advanced liver
disease have a greater incidence of ARF after OLT.11 Likewise,
Gonwa et al.4 found a higher Child–Pugh score in patients
who need postoperative dialysis. In our study, there was a
greater incidence of ARF in Child–Pugh stage C cirrhotic
patients, but in the multivariate study of the individual
components of this classification only hypoalbuminemia was
an independent risk factor. As far as we know, this is a new
finding in liver transplantation. When interpreting this
finding, it should be taken into consideration that the
population studied is not composed exclusively of patients
with liver cirrhosis. Thus, the Child–Pugh clinical variables
(ascitis and encephalopathy) have only been recorded in
cirrhotic patients, whereas the biochemical variables (albu-
min, bilirubin, and the prothrombin time) have been
considered in all the patients studied. From a physiopatho-
logical point of view, hypoalbuminemia may increase the
likelihood of ARF, since it modifies Starling’s forces in the
systemic capillaries, reduces the glomerular filtration,21 and
alters the pharmacokinetics of potentially nephrotoxic
drugs.22
Changes in the hemodynamic parameters during surgery
have an effect on the development of E-ARF, as shown by the
results of univariate analysis. Patients with E-ARF had a
lower systolic arterial pressure and MAP during the anhepatic
and post-anhepatic phases, and lower cardiac index during
the post-anhepatic phase. These data suggest that the patients
with E-ARF have more problems withstanding the OLT
hemodynamic changes, although we cannot state categori-
cally that they suffer cardiac failure. Grande et al.20 found a
lower MAP during anesthesia induction and during the
anhepatic phase in patients with postoperative ARF, although
only MAP (70 mmHg) during anesthesia induction was an
independent risk factor. Bilbao et al.3 found a more frequent
use of vasoactive drugs in patients who required RRT after
OLT. In our series, the patients with E-ARF also had a greater
need for infused blood products and adrenergic agonist drugs
during and after OLT than patients without E-ARF. However,
it was the duration of the treatment with dopamine during
the postoperative period which showed an independent
correlation with E-ARF. We believe that a more prolonged
use of dopamine in patients with E-ARF, in our study,
indicates the patients with greater hemodynamic instability
and thus more susceptibility to suffering ARF.
Dysfunction of the liver graft (grades II–IV) is another
important variable that independently correlates with E-ARF.
Bilbao et al.3 found severe dysfunction (III–IV) of the liver
graft to be a predictive factor of the need for postoperative
dialysis. In our case, moderate dysfunction (grade II,
AST41000 U/l) also is associated with postoperative
E-ARF. Both chronic and acute liver dysfunction produces
different types of renal disease, in particular the hepatorenal
syndrome.23 On the other hand, the exact mechanisms that
Table 6 | Comparison of preoperative, intraoperative and postoperative variables in OLT patients who did or did not develop
L-ARF (univariate analysis)
Period Variable L-ARF (n=34) Non L-ARF (n=144) P
Preoperative Elective retransplant 7 (21) 9 (6) o0.05
Preoperative ARF 6 (18) 7 (5) o0.05
Intraoperative Platelets (units) 11.378.1 7.7710 o0.01
Operative incidents 8 (24.2) 14 (10.1) o0.05
Postoperative Mechanical ventilation (days) 575.9 3.274.1 o0.05
Platelets (units) 16714 9.8713 o0.05
Surgical re-operation 18 (53) 24 (17) o0.001
Bacterial infection 19 (56) 29 (20) o0.001
The values are number and (%) of patients.
The results of quantitative data are expressed as mean7s.d.
L-ARF, late acute renal failure; OLT, orthotopic liver transplantation.
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cause primary dysfunction of the liver graft are unknown,
although ischemia–reperfusion appears to play an important
role.17 We may conclude that there is an independent relation
between liver dysfunction and ARF after OLT. Our results
enable us to affirm that any measure which improves
maintenance of the donor, perfusion of the liver graft, and
its conservation will result in better initial functioning of the
liver transplant and an improvement in the postoperative
renal function.
Risk factors for L-ARF
In our experience, once the first week after OLT has elapsed
the rate of ARF decreases, while the etiology and risk factors
of ARF also change. In L-ARF, preoperative and intraopera-
tive variables lose importance as prognostic factors for ARF.
In L-ARF it is the postoperative variables that become more
important and moreover are different from those found in
E-ARF. The only independent risk factors for L-ARF that have
been found are bacterial infection and surgical re-operation.
Most bacterial infections occur in the first 2 months post-
OLT; they are produced by microorganisms that are typically
nosocomial, and are the main cause of death during this
period. Septic shock is a main cause of ARF, and has been
shown to be an independent risk factor for acquired ARF in a
hospital setting.24 In OLT, patients who need postoperative
RRT have infections more frequently.3 Likewise, major
surgery infection has been identified also as an independent
risk factor in the need for dialysis during the first month after
OLT.25 From a physiopathological point of view, sepsis causes
systemic arterial vasodilation and intra-renal vasoconstric-
tion, and also facilitates the harmful action of other injuries
on the kidneys.26,27
In the study by Bilbao et al.,3 patients who needed RRT
post-OLT were more frequently re-operated on. In our series,
re-operation was, in addition, an independent risk factor for
L-ARF. Re-operation implies another aggression on the
delicate physiological equilibrium of a patient convalescing
of OLT. Anesthesia and the surgery itself lead to hemo-
dynamic and hormonal changes that are conducive to
postoperative ARF.28
Experimental evidence exists which indicates that the
occlusion of the inferior cava vein produces ischemic ARF.29
However, the PGB, which is widely used in Europe,30 is
linked to a lower incidence of ARF post-OLT, according to
some authors.9,31 One of the aims of our study was to analyze
whether the change from the standard technique (with or
without venovenous bypass) to the PGB altered the incidence
of ARF after OLT. The result of the univariate analysis enables
us to assert that the PGB significantly reduces the rate of
postoperative E-ARF. However, the surgical variable in the
analysis of logistical regression loses predictive power and
does not appear as an independent risk factor.
The results of our study enable us to conclude that the risk
factors for postoperative ARF in OLT vary according to the
time elapsed since surgery. The development of E-ARF is
influenced by preoperative factors such as acute renal
insufficiency and hypoalbuminemia, as well as postoperative
factors such as poor function of the liver graft and treatment
with a vasoactive drug (dopamine). However, in the late
postoperative period, preoperative variables become less
important as prognostic factors for L-ARF, and other
postoperative variables (surgical re-operation and bacterial
infection), which are different from those in the early period,
affect the outcome.
MATERIALS AND METHODS
We have retrospectively studied the clinical records of 200
consecutive OLT performed between 1991 and 1997. We have
chosen this period of time so that we can compare OLT performed
using the standard technique (without or with venovenous bypass)
to OLT carried out using PGB (inferior vena cava preservation),
while other conditions, such as the surgical team and immunosup-
pressive therapy, were similar. This enabled us to evaluate the
influence of the surgical technique on postoperative ARF. Since 1997
all OLT have been performed using the PGB, and both the surgical
team and the immunosuppression guidelines have varied.
We excluded 16 OLT: eight because of patient death and
eight because of premature failure of the liver graft within the
first 72 h after OLT. Of the patients who died, five were operated on
using the standard technique and three using PGB. The causes
of death were hypovolemic shock due to postoperative bleeding
(n¼ 4), multiorgan failure (n¼ 3), and ventricular fibrillation
(n¼ 1). Of the eight OLT with premature failure of the liver
graft, six were operated on using the standard technique and
two using PGB. The causes of the graft failure were primary
non-function (n¼ 6), arterial thrombosis (n¼ 1), and suprahepatic
vein thrombosis (n¼ 1).
We have divided the postoperative into early (first week post-
OLT) and late (second to fourth week post-OLT), and we have
studied the episodes of ARF in each case and then classified them as
E-ARF and L-ARF, accordingly. There were 184 patients in the early
postoperative period, and 178 in the late period (due to the death of
six patients in the early postoperative period).
The demographic data of the patients are shown in Table 7.
Postoperative ARF was defined as a 50% or greater increase in
postoperative S-Cr compared to pretransplant values.32,33 The
etiological categories of ARF were as follows:2,32
Prerenal azotemia was diagnosed in patients with evidence of
hypovolemia or hypotension in whom the S-Cr returned to base
values after the volemia or hypotension had been corrected. In
addition, urinalysis had to have a high osmolality and a low Naþ
excretion. Although the term ARF would not be used to apply to
these patients by most authors, a significant rise in S-Cr is often
called ARF.2
Ischemic acute tubular necrosis was diagnosed when severe and
prolonged hypovolemia or hypotension was observed. The S-Cr,
which had initially risen sufficiently to satisfy the criteria of ARF, did
not decline after treating volume depletion or hypotension.
Urinalysis was consistent with acute tubular necrosis (at least low
osmolality and high Naþ excretion).
Cyclosporine nephrotoxicity was the only etiology for ARF if the
rise in level of S-Cr coincided with high levels of cyclosporine and
then dropped to base level after a reduction in the cyclosporine
dosage in the absence of any other corrective measures.
We have defined ARF associated with sepsis as nitrogen retention
temporarily linked to a septic episode. Sepsis was diagnosed in an
1078 Kidney International (2006) 69, 1073–1080
o r i g i n a l a r t i c l e JB Cabezuelo et al.: Postoperative ARF in liver transplantation
appropriate clinical setting when at least one of the following
conditions was present: documented bacteriemia, a known focus
infection, immunosuppression with neutropenia, and at least two of
the following findings had been documented at the same time:
Tao361C or 4381C, hyperventilation, unexplained sudden fall in
blood pressure, and leukocytosis to more than 15 000.34
Multifactorial-ARF was defined as episodes of ARF in which two
or more causes that precede are identified, but when it is not
possible to choose between one or the other as the principal cause.
Hepatorenal syndrome was considered when all the major
criteria of the International Ascites Club were fulfilled.35
We have used the continuous arterio-venous hemofiltration
(femoral artery to jugular vein) as the intraoperative RRT. This
makes hemofiltration also possible in the anhepatic phase of the
standard technique. Also, we have used the intermittent hemodia-
lysis in the postoperative period.
During the surgical operation, furosemide 1 mg/kg/h was
administered when the diuresis dropped to below 1 ml/kg/h. The
essential hemodynamic objective was to maintain a MAP equal or
superior to 70 mmHg. In order to achieve this, and only after
ensuring that the cardiac preload was sufficient, dobutamine was
used when systolic dysfunction existed and noradrenaline was used
when the systemic vascular resistance index was low and the systolic
function and the cardiac preload were normal.
We collected the following data on potential risk factors for ARF:
Preoperative variables recipient: age, sex, pretransplantation
comorbidity (arterial hypertension, diabetes mellitus, nephropathy,
and abdominal surgery), indication for transplant, etiology, and
clinical presentation of the cirrhosis, Child–Pugh stage, united
network for organ sharing status, serum bilirubin, serum albumin,
prothrombin time, S-urea, S-Cr, urinary alterations (proteinuria
and/or hematuria), and some donor’s data (age, sex, cause of death,
blood group, and number of days in the intensive care unit).
Preoperative ARF was defined as a 50% or greater increase in S-Cr
compared to baseline values.
Intraoperative variables: the hemodynamic variables systolic
arterial pressure, MAP, pulmonary capillary wedge pressure, cardiac
index, and systemic vascular resistance index were measured at three
different times during the operation. The non-hemodynamic variables
were surgical technique, number of blood products infused (platelet
and red blood cells, fresh frozen plasma, and cryoprecipitates), need
for dobutamine and noradrenaline, and intraoperative complications.
Postoperative variables: duration of stay in the intensive care
unit, time on mechanic ventilation, liver graft dysfunction according
to Greigg et al.,36 need for dobutamine and dopamine in the first
week, blood products infused in the first week, episodes of acute
rejection, re-operations, and bacterial infections. In the post-
operative period, dopamine was used as a vasoactive drug at a dose
of 2–3 mg/kg/min in patients with refractory hypotension and a risk
of renal hypoperfusion, rarely noradrenaline.
The dose of cyclosporin was 4–5 mg/kg/day. The first dose was
given 12 h after surgery and subsequently adjusted according to
trough levels of 250–350 ng/ml.
Statistical analysis was performed comparing the groups of
patients with E-ARF and L-ARF to those with no ARF. Mann
Whitney’s U-test or Student’s t-test was used (depending on the
normality conditions) to compare the means of quantitative
variables, while Pearson’s w2 or Fisher’s exact test was used for
qualitative data. Those variables which showed statistical signifi-
cance (Po0.05) in the univariate analysis and which were relevant
were then subjected to multivariate analysis, by means of a logistic
regression model, in order to estimate the effect of their
interdependence. The cut-off point used for the quantitative data
was the median in the E-ARF group.
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